drugset / Trial / NCT00510159

Comparing Praziquantel Versus Artesunate + Sulfamethoxypyrazine/Pyrimethamine for Treating Schistosomiasis

NCT00510159

Phase 2/3 Completed 800 enrolled Dafra Pharma
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy of praziquantel versus As+SMP (Co-Arinate FDC ®) in the treatment of Schistosoma haematobium in 6-15 year old Malian children. The nul-hypothesis in this study is that the combination of As+SMP is more effective than praziquantel in the treatment of S. haematobium infected children.

Timeline

Start
2007-08
Primary completion
2007-10
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Artesunate Small molecule
Subject Praziquantel Small molecule
Subject pyrimethamine Small molecule
Subject sulfalene Small molecule